Optimizing antifungal strategies to improve patient survival

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2016) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance

(2016) Kelley R. Healey et al.   Nature Communications

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study

(2015) R. H. Jensen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Visual Hallucinations Associated with High Posaconazole Concentrations in Serum

(2015) Leighanne O. Parkes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

(2015) Paul E. Verweij et al.   DRUG RESISTANCE UPDATES

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

(2015) Oliver A. Cornely et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis

(2015) Marisa H. Miceli et al.   MYCOSES

Switching from Posaconazole Suspension to Tablets Increases Serum Drug Levels in Leukemia Patients without Clinically Relevant Hepatotoxicity

(2014) Dong Sik Jung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Pharmacodynamics of Posaconazole in Neutropenic Murine Models of Invasive Pulmonary Aspergillosis and Mucormycosis

(2014) Russell E. Lewis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin resistance

(2014) Maiken C. Arendrup et al.   CURRENT OPINION IN INFECTIOUS DISEASES

The role of azoles in the management of azole-resistant aspergillosis: From the bench to the bedside

(2014) Seyedmojtaba Seyedmousavi et al.   DRUG RESISTANCE UPDATES

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension

(2012) Gopal Krishna et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

(2011) M. R. Ananda-Rajah et al.   HAEMATOLOGICA

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Echinocandin‐Based Initial Therapy in Fungemic Patients with Cancer: A Focus on Recent Guidelines of the Infectious Diseases Society of America

(2009) Dimitrios P. Kontoyiannis   CLINICAL INFECTIOUS DISEASES